Close Menu

More articles about Neurological & Psychological Disorders

The Alzheimer's Disease Neuroimaging Initiative said that it has nearly finished its genome-wide analysis and plans to make the data from this project freely available to the research community.

Still, the company remains optimistic about therapeutic RNAi and continues target-identification efforts in preparation for when it raises the funds necessary to begin new programs incorporating the gene-silencing technology.

Snippets: Mar 11, 2009

Premium

Chronix Biomedical, Rosetta Genomics, National Institute of General Medical Sciences, National Center for Genome Resources, Beyond Batten Disease Research Foundation, and more ...

During the firm's earnings call last week, CEO Amit Kumar said that the company's diagnostics services performance would be most indicative of how CombiMatrix would perform going forward.

Researchers in the Neuromuscular Disorder-Chip Consortium will use custom-designed NimbleGen Human CGH 12x135K microarrays and Human Sequence Capture 385K arrays to study the genetic underpinnings of a range of neuromuscular disorders.

The partners are deciding whether to run the multiplex test on a microarray or a sequencing platform. Factors in the decision include the complexity of the test and the technical feasibility of multiplexed, targeted resequencing.

Chronix Biomedical said that the current study confirms its previous research showing that CNAs can identify the presence of certain diseases in blood samples months to years before clinical symptoms appear.

The cells, derived from patients with sporadic Parkinson's disease, remained pluripotent, and revealed a gene-expression profile that more closely resembled human embryonic stem cells than human iPS cells still carrying the reprogramming factors.

IP Update: Mar 5, 2009

Premium

USPTO Publishes One Patent, Eight Patent Applications Related to RNAi

At the public meeting, speakers from groups representing employers and employees pointed out the need for the EEOC to clarify "inadvertent acquisition" of genetic information under which employers would not be held in violation of the law and to provide specific examples of the types of genetic information linked to "manifested diseases" which the law does not protect.

Snippets: Mar 4, 2009

Premium

DNAPrint, Laboratory Corporation of America, Duke University, Lab21, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Diseases and Stroke, and more …

Genescient will analyze Kronos' Alzheimer's disease data set to try and find genes not previously linked to the disease.

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

News Scan: Feb 27, 2009

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

The Umbrella Institute

Premium

The Hunter Medical Research Institute was started to bring together biomedical and clinical scientists — and the results have been so positive that it has become a model for how to accomplish translational research.

BioGenes will supply antibodies for the project, called cNeupro. The deal will enable it to share ownership of the antibodies and pocket royalties on the ones that lead to commercial products.

Industry Briefs: Feb 26, 2009

Premium

Mosaiques, Bruker, Kinaxo, Xencor, CSL, Hybrigenics, Adlyfe, Wyeth

Clinical Data will use the funds to support late-stage development of two of its drugs.

A European consortium involving more than a dozen research institutions will use NimbleGen arrays in their study of neuromuscular disorder genetics.

Multiple Personalities

Premium

With its hybrid-core tool, an innovative hardware vendor gives clusters a run for their money — while promising to save yours.

Pages

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

Researchers have developed a robotic lab assistant, the Verge reports.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.